167 related articles for article (PubMed ID: 30901393)
1. An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals.
Klaric JS; Beltran TA; McClenathan BM
Mil Med; 2019 Mar; 184(Suppl 1):126-132. PubMed ID: 30901393
[TBL] [Abstract][Full Text] [Related]
2. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
[TBL] [Abstract][Full Text] [Related]
3. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
4. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
5. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
[TBL] [Abstract][Full Text] [Related]
6. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.
Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C
Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368
[TBL] [Abstract][Full Text] [Related]
7. Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
Draper M; Stergiopoulos S
Vaccine; 2021 Nov; 39(46):6781-6786. PubMed ID: 34625290
[TBL] [Abstract][Full Text] [Related]
8. Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years.
Tseng HF; Harpaz R; Luo Y; Hales CM; Sy LS; Tartof SY; Bialek S; Hechter RC; Jacobsen SJ
J Infect Dis; 2016 Jun; 213(12):1872-5. PubMed ID: 26908728
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC
Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study.
Baxter R; Bartlett J; Fireman B; Marks M; Hansen J; Lewis E; Aukes L; Chen Y; Klein NP; Saddier P
Am J Epidemiol; 2018 Jan; 187(1):161-169. PubMed ID: 29309521
[TBL] [Abstract][Full Text] [Related]
11. The effect of a prescription order requirement for pharmacist-administered vaccination on herpes zoster vaccination rates.
Tak CR; Gunning K; Kim J; Sherwin CM; Ruble JH; Nickman NA; Biskupiak JE
Vaccine; 2019 Jan; 37(4):631-636. PubMed ID: 30563788
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Gomes Silva BN; Torloni MR; Soares BG
Cochrane Database Syst Rev; 2012 Oct; 10():CD008858. PubMed ID: 23076951
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
Lu PJ; Euler GL; Harpaz R
Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study.
Valente N; Lupi S; Stefanati A; Cova M; Sulcaj N; Piccinni L; ; Gabutti G
BMJ Open; 2016 Oct; 6(10):e011539. PubMed ID: 27797989
[TBL] [Abstract][Full Text] [Related]
15. Clinical Efficacy of Pretransplant Vaccination for Preventing Herpes Zoster After Living Donor Liver Transplantation in Recipients Age 50 Years and Older.
Cho CW; Kim JM; Choi GS; Joh JW
Ann Transplant; 2019 Apr; 24():208-213. PubMed ID: 30992423
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
[TBL] [Abstract][Full Text] [Related]
17. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ
Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481
[TBL] [Abstract][Full Text] [Related]
18. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.
Horn J; Damm O; Greiner W; Hengel H; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Karch A; Mikolajczyk RT
BMC Med; 2018 Jan; 16(1):3. PubMed ID: 29316913
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
[TBL] [Abstract][Full Text] [Related]
20. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]